Background: Catheter-associated urinary tract infection is the most common hospital-acquired infection which is treated empirically by quinolone antibiotics. Analysis of clinical characteristics, risk factors, and common pathogens has a major effect on the advancement of the prevention of CAUTI in medical settings. Subjects and Methods: Urine samples were collected from Intensive Care Units at Mansoura University Main Hospital over two years. Samples were then transferred to the Microbiology lab, at Mansoura University Main Hospital for culture, identification, and sensitivity Results: The most common pathogens were E. coli (27.4%) followed by Candida (21.2%) and Staph aureus (12.0 %). Females were slightly higher (52 %) than males (48 %). diabetes appeared to be the most common risk factor (31% of cases) followed by chronic kidney disease (23.5%) and cerebrovascular accidents (23%). Meropenem was the highest sensitive antibiotic (48.9%) followed by amikacin (47.4%), norfloxacin (46.2%), imipenem (41.8) while cefuroxime (100.0%), and cefaclor (100.0%) are the most resistant antibiotic followed by ceftriaxone (97.0%), doxycycline (96.0%). Conclusion: cases in our study showed a high resistance rate to quinolone antibiotics which need infection control plans and antibiotic stewardship programs to reduce that rate.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.